Medical therapy for patients with subclinical and clinical carotid atherosclerosis

Egle Corrado, Cinzia Nugara, Filippo Ferrara, Salvatore Novo, Daniela Bacarella, Giuseppe Coppola, Sonia Dell'Oglio

Risultato della ricerca: Article

1 Citazione (Scopus)

Abstract

The management of carotid artery disease includes both modifications in life style as well treatment of vascular risk factors. However, strict risk factor modification, including improved antihypertensive therapy, lipid management, smoking cessation, and antiplatelet therapy, promise for reducing the vascular event rate in patients with carotid atherosclerosis. The best medical management for stroke prevention was highlighted in clinical practice guidelines issued jointly in 2006 by the American Heart Association and the American Stroke Association, and co-sponsored by the Council on Cardiovascular Radiology and Intervention and the American Academy of Neurology. Lowering blood pressure to a target below 120/80 mm Hg by life style interventions and antihypertensive treatment. Glucose control to near-normoglycemic levels (target hemoglobin A1C ≤7%) is recommended among diabetics to reduce micro-vascular complications and, with lesser certainty, macrovascular complications. The primary objective of this review is to summarize the current evidence and standards for the advanced diagnostic and management strategies used in asymptomatic and symptomatic patients with carotid atherosclerosis.
Lingua originaleEnglish
pagine (da-a)1-9
Numero di pagine9
RivistaDefault journal
Volume31
Stato di pubblicazionePublished - 2012

Fingerprint

Carotid Artery Diseases
Antihypertensive Agents
Blood Vessels
Life Style
Smoking Cessation
Therapeutics
Practice Guidelines
Radiology
Hemoglobins
Stroke
Blood Pressure
Lipids
Glucose

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cita questo

Medical therapy for patients with subclinical and clinical carotid atherosclerosis. / Corrado, Egle; Nugara, Cinzia; Ferrara, Filippo; Novo, Salvatore; Bacarella, Daniela; Coppola, Giuseppe; Dell'Oglio, Sonia.

In: Default journal, Vol. 31, 2012, pag. 1-9.

Risultato della ricerca: Article

@article{d24bbbd37b904759970cea9be4648c43,
title = "Medical therapy for patients with subclinical and clinical carotid atherosclerosis",
abstract = "The management of carotid artery disease includes both modifications in life style as well treatment of vascular risk factors. However, strict risk factor modification, including improved antihypertensive therapy, lipid management, smoking cessation, and antiplatelet therapy, promise for reducing the vascular event rate in patients with carotid atherosclerosis. The best medical management for stroke prevention was highlighted in clinical practice guidelines issued jointly in 2006 by the American Heart Association and the American Stroke Association, and co-sponsored by the Council on Cardiovascular Radiology and Intervention and the American Academy of Neurology. Lowering blood pressure to a target below 120/80 mm Hg by life style interventions and antihypertensive treatment. Glucose control to near-normoglycemic levels (target hemoglobin A1C ≤7{\%}) is recommended among diabetics to reduce micro-vascular complications and, with lesser certainty, macrovascular complications. The primary objective of this review is to summarize the current evidence and standards for the advanced diagnostic and management strategies used in asymptomatic and symptomatic patients with carotid atherosclerosis.",
keywords = "Therapy, atherosclerosis",
author = "Egle Corrado and Cinzia Nugara and Filippo Ferrara and Salvatore Novo and Daniela Bacarella and Giuseppe Coppola and Sonia Dell'Oglio",
year = "2012",
language = "English",
volume = "31",
pages = "1--9",
journal = "Default journal",

}

TY - JOUR

T1 - Medical therapy for patients with subclinical and clinical carotid atherosclerosis

AU - Corrado, Egle

AU - Nugara, Cinzia

AU - Ferrara, Filippo

AU - Novo, Salvatore

AU - Bacarella, Daniela

AU - Coppola, Giuseppe

AU - Dell'Oglio, Sonia

PY - 2012

Y1 - 2012

N2 - The management of carotid artery disease includes both modifications in life style as well treatment of vascular risk factors. However, strict risk factor modification, including improved antihypertensive therapy, lipid management, smoking cessation, and antiplatelet therapy, promise for reducing the vascular event rate in patients with carotid atherosclerosis. The best medical management for stroke prevention was highlighted in clinical practice guidelines issued jointly in 2006 by the American Heart Association and the American Stroke Association, and co-sponsored by the Council on Cardiovascular Radiology and Intervention and the American Academy of Neurology. Lowering blood pressure to a target below 120/80 mm Hg by life style interventions and antihypertensive treatment. Glucose control to near-normoglycemic levels (target hemoglobin A1C ≤7%) is recommended among diabetics to reduce micro-vascular complications and, with lesser certainty, macrovascular complications. The primary objective of this review is to summarize the current evidence and standards for the advanced diagnostic and management strategies used in asymptomatic and symptomatic patients with carotid atherosclerosis.

AB - The management of carotid artery disease includes both modifications in life style as well treatment of vascular risk factors. However, strict risk factor modification, including improved antihypertensive therapy, lipid management, smoking cessation, and antiplatelet therapy, promise for reducing the vascular event rate in patients with carotid atherosclerosis. The best medical management for stroke prevention was highlighted in clinical practice guidelines issued jointly in 2006 by the American Heart Association and the American Stroke Association, and co-sponsored by the Council on Cardiovascular Radiology and Intervention and the American Academy of Neurology. Lowering blood pressure to a target below 120/80 mm Hg by life style interventions and antihypertensive treatment. Glucose control to near-normoglycemic levels (target hemoglobin A1C ≤7%) is recommended among diabetics to reduce micro-vascular complications and, with lesser certainty, macrovascular complications. The primary objective of this review is to summarize the current evidence and standards for the advanced diagnostic and management strategies used in asymptomatic and symptomatic patients with carotid atherosclerosis.

KW - Therapy

KW - atherosclerosis

UR - http://hdl.handle.net/10447/79262

M3 - Article

VL - 31

SP - 1

EP - 9

JO - Default journal

JF - Default journal

ER -